click below
click below
Normal Size Small Size show me how
PHM1810 Chp 10 Drug
Pharmacology I: Chapter 10: Musculoskeletal (Entire)
| Question | Answer |
|---|---|
| Anectine | succinylcholine chl; neuromuscular blocking agent |
| Tracrium | atracurium besylate; neuromuscular blocking agent |
| Nimbex | cisatracurium besylate; neuromuscular blocking agent |
| Zemuron | rocuronium bromide; neuromuscular blocking agent |
| Nuromax | doxacurium chloride; neuromuscular blocking agent |
| Mivacron | mivacurium chloride; neuromuscular blocking agent |
| Pavulon | pancuronium bromide; neuromuscular blocking agents |
| Lioresal | baclofen; centrally acting skeletal muscle relaxant |
| Soma | carisoprodol; centrally acting skeletal muscle relaxant |
| Maolate | chlorphenesin carbamate; centrally acting skeletal muscle relaxant |
| Parafon Forte/Paraflex | chlorzoxazone; centrally acting skeletal muscle relaxant |
| Flexeril | cyclobenzaprine; centrally acting skeletal muscle relaxant |
| Valium | diazepam; centrally acting skeletal muscle relaxant |
| Robaxin | methocarbamol; centrally acting skeletal muscle relaxant |
| Norflex | orphanadrine citrate; centrally acting skeletal muscle relaxant |
| Botox | botulinium toxin type A; Direct-acting anti-spasmodic agents |
| Myoblock | botulinium toxin type B; Direct-acting antispasmodic agents |
| Dantrium | dantrolene sodium; Direct-acting antispasmodic agents |
| Quinamm | quinine sulfate; diect-acting antispasmodic agent |
| Ridaura | auranofin; 2nd line agents for Rheumatoid Arthritis |
| Aurolate | gold sodium thiomalate; 2nd line agents for Rheumatoid Arthritis |
| Mexate | methotrexate; 2nd line agents for Rheumatoid Arthritis |
| Plaquenil | hydrochloroquine; 2nd line agents for Rheumatoid Arthritis |
| Depen | penicillamine; 2nd line agents for Rheumatoid Arthritis |
| Azulfadine | sulfasalazine; 2nd line agents for Rheumatoid Arthritis |
| Mechanism of Action of Neuromuscular Agents | prevent somatic motor nerve impulses, which affect skeletal muscles |
| Adverse Effects of Neuromuscular Agents | drowsiness, dry mouth, loss of strength, hypotension, muscle weakness, cardiac arrythmias, increase in seizures in epileptics |
| Mechanism of Action of Centrally-Acting Skeletal Muscle Relaxants | Unknown; May act in the CNS to depress polysynaptic reflexes. |
| Adverse Effects of Centrally-Acting Agents | weakness, fatigue, drowsiness, dizziness |
| Mechanism of Action of Direct Acting Agents | Inhibit release of calcium ions, making the musces less responsive to nerve impulses. |
| Adverse Effects of Direct Acting Agents | muscle weakness, drowsiness, dizziness, nausea, diarrhea, seizures, tachycardia, erratic BP and pericarditis |
| Mechanism of Action for RA Drugs | Unknown; Gold compounds, however, suppress or prevent inflammation but do not sure it |
| Adverse Effects of RA Drugs | gold compounds and penicillamine: GI disturbances, dermatitis, lesions of mucous membranes; Corticosteroids: GI bleeding, poor wound healing, hyperglycemia, hypertension and osteoporosis (long term use) |
| Colcrys | colchicine; used for gout; mechanism of action unknown; adverse effects: very toxic!! stop if diarrhea, vomiting, abdominal pain |
| Zyloprim | allopurinol; used for gout; blocks the formation of /enhances the excretion of uric acid; adverse effects: drowsiness, headache, vertigo, nausea, GI discomfort, hepatoxicity, renal insufficiency |